D. Szabó

发表

Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease

G. Veres, A. Szabó, A. Kiss, 2016, Inflammatory bowel diseases.

Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.

G. Veres, M. Papp, P. Lakatos, 2013, Journal of Crohn's & colitis.

Pancreatic Autoantibodies and Autoantibodies Against Goblet Cells in Pediatric Patients With Inflammatory Bowel Disease

G. Veres, M. Papp, P. Lakatos, 2012, Journal of pediatric gastroenterology and nutrition.

The Covert Surge: Murine Bile Acid Levels Are Associated With Pruritus in Pediatric Autoimmune Sclerosing Cholangitis

M. Wagner, A. Dezsőfi, J. Jahnel, 2022, Frontiers in Pediatrics.

Incidence, Paris Classification, and Follow-up in a Nationwide Incident Cohort of Pediatric Patients With Inflammatory Bowel Disease

G. Veres, M. Papp, P. Lakatos, 2013, Journal of pediatric gastroenterology and nutrition.

Seasonal variability of vitamin D and bone metabolism in infliximab-treated paediatric Crohn's disease.

G. Veres, M. Papp, P. Lakatos, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[Successful autologous haematopoietic stem cell transplantation in severe, therapy-resistant childhood Crohn's disease. Report on the first case in Hungary].

G. Veres, J. Sinko, A. Arató, 2014, Orvosi hetilap.

[Analysis of infliximab treated pediatric patients with Crohn disease in Hungary].

G. Veres, A. Arató, E. Tomsits, 2010, Orvosi hetilap.

[Adalimumab treatment in infliximab-resistant pediatric patient with Crohn's disease].

G. Veres, A. Arató, A. Dezsőfi, 2009, Orvosi hetilap.

Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry.

G. Veres, M. Papp, P. Lakatos, 2012, Journal of Crohn's & colitis.

Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease.

G. Veres, M. Papp, P. Lakatos, 2014, Journal of Crohn's & colitis.

[Genetic and epigenetic aspects of celiac disease].

G. Veres, A. Arató, N. Béres, 2014, Orvosi hetilap.

Joint involvement, disease activity and quality of life in pediatric Crohn’s disease – a cross-sectional study

G. Veres, G. Rudas, Á. Cseh, 2022, Pediatric Rheumatology.

Role of the Microbiome in Celiac Disease

G. Veres, A. Szabó, A. Arató, 2014 .

Altered activation of peripheral CD8+ T cells in pediatric Crohn's disease.

G. Veres, B. Vásárhelyi, T. Tulassay, 2017, Immunology Letters.

Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patterns

G. Veres, B. Vásárhelyi, T. Tulassay, 2016, Oncotarget.

Cardiovascular Risk Assessment in Pediatric Liver Transplant Patients

A. Dezsőfi, E. Kis, G. Reusz, 2019, Journal of pediatric gastroenterology and nutrition.

Peroxisome proliferator-activated receptor-γ and thymic stromal lymphopoietin are involved in the pathophysiology of childhood coeliac disease

G. Veres, T. Tulassay, A. Arató, 2014, Virchows Archiv.

Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease

G. Veres, A. Szabó, A. Kiss, 2016, Inflammatory bowel diseases.

Altered activation of peripheral CD8+ T cells in pediatric Crohn's disease.

G. Veres, B. Vásárhelyi, T. Tulassay, 2017, Immunology letters.

Seasonal variability of vitamin D and bone metabolism in infliximab-treated paediatric Crohn's disease.

G. Veres, M. Papp, P. Lakatos, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.